Management of Acute Watery Diarrhea in Healthy Adults
Begin reduced-osmolarity oral rehydration solution (65–70 mEq/L sodium, 75–90 mmol/L glucose) immediately and avoid empiric antibiotics—rehydration prevents morbidity and mortality, not the diarrhea itself. 1
Immediate Rehydration Strategy (First Priority)
Prescribe 2,200–4,000 mL per day of reduced-osmolarity ORS, with the rate exceeding ongoing losses (urine output + 30–50 mL/hour insensible losses + stool volume). 2
For mild dehydration (3–5% fluid deficit): Give 50 mL/kg ORS over 2–4 hours. 2
For moderate dehydration (6–9% deficit): Give 100 mL/kg ORS over 2–4 hours. 2
Continue ORS until clinical dehydration resolves and diarrhea stops—this is a strong recommendation with high-quality evidence from the Infectious Diseases Society of America. 1
Switch to intravenous isotonic fluids (lactated Ringer's or normal saline) immediately if severe dehydration (≥10% deficit), altered mental status, inability to tolerate oral intake, or shock develops. 1
Maintain IV fluids until pulse, perfusion, and mental status normalize, then transition back to ORS to replace the remaining deficit. 1
Dietary Management
Resume a normal diet immediately after rehydration is complete—do not withhold food, as early refeeding prevents malnutrition and may reduce stool output. 1
Start with small, light meals and avoid fatty, heavy, spicy foods, caffeine, and lactose-containing products during the acute phase. 2
Antimotility Therapy (Loperamide)
Loperamide may be used only after adequate rehydration in immunocompetent adults with watery diarrhea—this is a weak recommendation with moderate evidence. 1
Dosing: 4 mg initially, then 2 mg after each unformed stool, maximum 16 mg per 24 hours. 2, 3
Loperamide is absolutely contraindicated if fever or bloody stools are present because of the risk of toxic megacolon in inflammatory diarrhea—this is a strong recommendation. 1
Never prioritize loperamide over rehydration—dehydration, not diarrhea, drives morbidity and mortality. 2
Antibiotic Stewardship (Critical)
Do NOT prescribe empiric antibiotics for uncomplicated acute watery diarrhea in stable, immunocompetent adults without recent international travel—this is a strong recommendation from IDSA. 1, 2
Antibiotics are reserved ONLY for:
When antibiotics ARE indicated: Azithromycin is preferred (500 mg single dose for watery diarrhea; 1,000 mg single dose for dysentery) due to rising fluoroquinolone resistance in Campylobacter. 2, 5
Alternative regimens: Ciprofloxacin 750 mg single dose or levofloxacin 500 mg single dose, based on local resistance patterns. 2, 5
Adjunctive Therapies
Probiotics may be offered to reduce symptom severity and duration—this is a weak recommendation with moderate evidence. 1
Antiemetics (ondansetron) may be considered after adequate rehydration to facilitate ORS tolerance, but they do not replace fluid therapy. 1
Critical Red Flags Requiring Escalation
Prolonged skin tenting (>2 seconds), cool/poorly perfused extremities, or decreased capillary refill indicate severe dehydration requiring immediate IV fluids. 2
Bloody stools without fever require Shiga-toxin testing BEFORE any antibiotics—antimicrobials markedly increase hemolytic-uremic syndrome risk in STEC infections. 2
Altered mental status, persistent tachycardia, or hypotension mandate immediate IV rehydration and hospital evaluation. 1
Key Pitfalls to Avoid
Never use loperamide in children <18 years—this is a strong recommendation with moderate evidence. 1
Never start antibiotics for bloody diarrhea before ruling out STEC with Shiga-toxin testing. 2
Never delay IV rehydration in severe dehydration while attempting oral rehydration. 2
Never prescribe empiric antibiotics for uncomplicated watery diarrhea—this promotes antimicrobial resistance without clinical benefit. 1, 2
When to Obtain Stool Testing
Obtain stool studies only when: fever with bloody/mucoid stools, severe dehydration requiring hospitalization, immunosuppression, symptoms persisting >7–10 days, or suspected outbreak. 2, 4
Stool panel should include: bacterial cultures for Salmonella, Shigella, Campylobacter, Yersinia; Shiga-toxin testing; and C. difficile toxin if recent healthcare exposure or antibiotics. 2
Reassessment Timeline
- If no clinical improvement within 48–72 hours, reassess for antimicrobial resistance, ongoing fluid/electrolyte disturbances, or non-infectious etiologies (inflammatory bowel disease, medication-induced diarrhea). 2